Consequently,
Opacity risks dermatological tele -expertise:
The shortage of dermatologists. Similarly, the promise of early detection of skin cancers paved the way for deployment, in pharmacies, connected dermatoscopes, often associated with artificial intelligence algorithms. Consequently, Presented as solutions for the future. In addition, these devices make it possible to scan a suspicious lesion, to obtain an automated analysis, and sometimes a remote medical opinion.
But France Assos Santé denounces a deployment without safeguards, where marketing promises often take precedence over patient safety.
Devices little. Nevertheless, not certified – Opacity risks dermatological tele -expertise
Several devices offered in pharmacies do not have a solid medical certification, as the French Society of Dermatology (SFD) underlines in a recent press release. Nevertheless, Their diagnostic reliability, especially for melanomas, remains uncertain.
Cases of falsely reassured and too late patients have already been reported. Similarly, A major risk when you know that the prognosis for melanoma is based on early detection.
Medical supervision … opacity risks dermatological tele -expertise with variable geometry
Another reason for concern: the supervision of results by health professionals. Certain offers, sold as medical tele -expertise, are actually based on a sorting operated by artificial intelligence. Only the clichés deemed suspected by the algorithm would be transmitted to a dermatologist.
For France Assos Santé. this practice is incompatible with the requirement of a systematic human supervision, essential within the framework of a medical act.
Pharmacists invited to vigilance
France Assos Santé recalls that pharmacists have direct responsibility for the safety of the devices they offer. “” Pharmacists are guaranteeing the quality of the services they offer. They must ensure certifications of devices. especially when they integrate AI », Insists Chantal Cateau, president of the association Le Lien, cited in the press release.
A necessary reminder, while certain officers can be seduced by commercial arguments without verifying the conformity of the devices used.
Four requirements for responsible practices
France Assos Health opacity risks dermatological tele -expertise recalls the essential pillars to secure these practices:
– clear. loyal information of patients
– medical technologies certified by independent organizations
– a systematic human supervision of tele -expertise acts
– a necessary national regulation
The association calls for an action of the public authorities to supervise this market, prevent drifts and protect patients.
It also invites professional orders and pharmacists unions to seize the subject, to raise awareness, train and, if necessary, sanction.
AI, a promising lever … under conditions
France Assos Health recognizes the potential of artificial intelligence. especially in prevention, but insists on the need for controlled integration.
Philippe Bergerot. president of the National League against Cancer, recalls: ” Without supervision or transparency, these tools may blur the care path instead of optimizing it. »
The association also calls for public funding of certified devices, for the benefit of patients and the health system.
A major public health issue
In his ” Manifesto on artificial intelligence at opacity risks dermatological tele -expertise the bedside of patients ». France Assos Santé invites a collective commitment to guarantee ethical uses and responsible for AI systems.
Prevent cancers earlier, yes. But never at the expense of patient safety.
Further reading: A replacement solution is identified – Ehu of Oran: awareness of viral hepatitis – Alpacas: rare wool, gentle therapy and natural immersion – Newborn microbiome: a passport for immunity – Carla Bruni: This method she adopted so as not to gain weight during menopause.